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Fungal endophytes are living in plant tissues without any harmful effects. 
Remarkable part of these microorganisms are able to produce secondary 
metabolites resulted from the high biochemical pressure of the host 
environment. Furthermore, these synthetized metabolites could be beneficial 
for host plants to facilitate their nutrient uptake, to take part in the systemic 
regulation, to keep the fitness at high level or to prevent the pathogen 
infections. Moreover, due to the various bioactivities of these secondary 
metabolites involving the antimicrobial effects, they could be potential 
candidates for the future applications in medical treatments against human 
pathogenic microorganisms. 
In this study, the extracts of ferment broths originated from the endophytic 
isolates of Taxus baccata were screened for their antibacterial effects. Tests 
were carried out against selected bacteria including Bacillus subtilis, 
Escherichia coli, Staphylococcus aureus, Micrococcus luteus, and 
Pseudomonas aeruginosa on microtiter plates. For further examinations, the 
H1-3a-RB endophytic isolate (identified as Penicillium sp.) was selected based 
on the remarkable inhibitory effect of its ferment broth on B. subtilis and E. 
coli. For large scale purification it was cultivated in large volume and the 
secondary metabolites were extracted by ethyl-acetate. Pooled extracts were 
introduced into an activity guided multi-step chromatographic separation. The 
first step within the procedure was a flash chromatographic separation using 
normal phase cartridges and toluene/isopropanol as mobile phase. For the 
injection, the extract was directly evaporated onto the stationary phase. During 
the separation 70 fractions were collected with equal volumes; all of these were 
tested against B. subtilis on microtiter plates. The active fractions were further 
examined by a UHPLC-HRMS instrument using J’sphere ODS-H80 (250*2,1 
mm, 4 µm) column and water/methanol gradient containing formic acid. Than 
the pooled crude fractions were subjected onto a reverse phase preparative 
column, where the collected fractions were tested again in the antibacterial 
 




bioassay and analysed with UHPLC-MS. The recorded total ion 
chromatograms of both crude and partially purified extract were compared, and 
some constituents of the metabolite were identified.  
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